Viewing Study NCT06903312


Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2026-01-01 @ 6:37 PM
Study NCT ID: NCT06903312
Status: RECRUITING
Last Update Posted: 2025-07-03
First Post: 2025-03-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module